Published in J Infect Dis on May 01, 1995
Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective. Biol Blood Marrow Transplant (2009) 5.10
Replication-deficient human adenovirus type 35 vectors for gene transfer and vaccination: efficient human cell infection and bypass of preexisting adenovirus immunity. J Virol (2003) 4.48
Quantifying adenovirus-neutralizing antibodies by luciferase transgene detection: addressing preexisting immunity to vaccine and gene therapy vectors. J Clin Microbiol (2003) 3.29
Prevalence of neutralizing antibodies to adenoviral serotypes 5 and 35 in the adult populations of The Gambia, South Africa, and the United States. Clin Diagn Lab Immunol (2004) 2.58
Canine adenovirus vectors: an alternative for adenovirus-mediated gene transfer. J Virol (2000) 2.00
Identification of hexon-specific CD4 and CD8 T-cell epitopes for vaccine and immunotherapy. J Virol (2007) 1.70
Recombinant adenovirus induces maturation of dendritic cells via an NF-kappaB-dependent pathway. J Virol (2000) 1.60
Established immunity precludes adenovirus-mediated gene transfer in rat carotid arteries. Potential for immunosuppression and vector engineering to overcome barriers of immunity. J Clin Invest (1997) 1.57
How I treat adenovirus in hematopoietic stem cell transplant recipients. Blood (2010) 1.29
Canine adenovirus type 2 attachment and internalization: coxsackievirus-adenovirus receptor, alternative receptors, and an RGD-independent pathway. J Virol (2000) 1.16
Three-dimensional structure of canine adenovirus serotype 2 capsid. J Virol (2008) 1.13
Extensive cross-reactivity of CD4+ adenovirus-specific T cells: implications for immunotherapy and gene therapy. J Virol (2003) 1.11
Adenovirus-pulsed dendritic cells stimulate human virus-specific T-cell responses in vitro. J Virol (1996) 1.04
Human adenovirus: Viral pathogen with increasing importance. Eur J Microbiol Immunol (Bp) (2014) 1.04
Frequency, proliferation, and activation of human memory T cells induced by a nonhuman adenovirus. J Virol (2005) 1.00
An update on canine adenovirus type 2 and its vectors. Viruses (2010) 1.00
Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol (1996) 0.96
Cytotoxic T lymphocytes as immune-therapy in haematological practice. Br J Haematol (2008) 0.95
Evaluation of cross-reactive cell-mediated immune responses among human, bovine and porcine adenoviruses. Gene Ther (2010) 0.90
Human T cell proliferative response to polypeptides from adenovirus type 2. J Infect Dis (1995) 0.89
Combined CD8+ and CD4+ adenovirus hexon-specific T cells associated with viral clearance after stem cell transplantation as treatment for adenovirus infection. Haematologica (2010) 0.88
Management of adenovirus in children after allogeneic hematopoietic stem cell transplantation. Adv Hematol (2013) 0.87
Identification of HI-like loop in CELO adenovirus fiber for incorporation of receptor binding motifs. J Virol (2007) 0.82
Comparison of in-house real-time quantitative PCR to the Adenovirus R-Gene kit for determination of adenovirus load in clinical samples. J Clin Microbiol (2010) 0.80
The promise and potential hazards of adenovirus gene therapy. Gut (2001) 0.78
Fell Pony syndrome: characterization of developmental hematopoiesis failure and associated gene expression profiles. Clin Vaccine Immunol (2012) 0.78
Immune-Complexed Adenovirus Induce AIM2-Mediated Pyroptosis in Human Dendritic Cells. PLoS Pathog (2016) 0.75
Results of allogeneic bone marrow transplants for leukemia using donors other than HLA-identical siblings. J Clin Oncol (1997) 2.79
Immunoregulatory properties of ISG15, an interferon-induced cytokine. Proc Natl Acad Sci U S A (1996) 2.45
T-lymphocyte subpopulations in patients with classic hemophilia treated with cryoprecipitate and lyophilized concentrates. N Engl J Med (1983) 1.91
Editors have ethical responsibilities, too. N Engl J Med (1984) 1.91
Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis. Cytotherapy (2007) 1.58
Prospective clinical trial of a human tumor cloning system. Cancer Res (1983) 1.44
Ability of circular extrachromosomal DNA molecules to carry amplified MYCN proto-oncogenes in human neuroblastomas in vivo. J Natl Cancer Inst (1990) 1.38
A new method for studying splenic reticuloendothelial dysfunction in sickle cell disease patients and its clinical application: a brief report. Blood (1976) 1.38
Engraftment and survival after unrelated-donor bone marrow transplantation: a report from the national marrow donor program. Blood (2000) 1.32
Consistent N-myc copy number in simultaneous or consecutive neuroblastoma samples from sixty individual patients. Cancer Res (1987) 1.31
Bone marrow transplantation from related donors other than HLA-identical siblings: effect of T cell depletion. Bone Marrow Transplant (1991) 1.23
Alternative complement pathway activity in sera from patients with sickle cell disease. Clin Exp Immunol (1976) 1.15
Successful allogeneic transplantation of T-cell-depleted bone marrow from closely HLA-matched unrelated donors. N Engl J Med (1990) 1.07
Graft-versus-leukaemia reactivity induced by alloimmunisation without augmentation of graft-versus-host reactivity. Nature (1979) 1.06
Detection of adenovirus DNA in peripheral blood mononuclear cells by polymerase chain reaction assay. J Med Virol (1997) 1.05
Long-term results of selective renal shielding in patients undergoing total body irradiation in preparation for bone marrow transplantation. Bone Marrow Transplant (1997) 1.04
Spontaneous, persistent infection of a B-cell lymphoma with adenovirus. J Med Virol (1996) 1.01
Alternative-donor hematopoietic stem-cell transplantation for severe aplastic anemia. Semin Hematol (2000) 0.98
Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion. Biol Blood Marrow Transplant (2001) 0.96
Human adenovirus-specific CD8+ T-cell responses are not inhibited by E3-19K in the presence of gamma interferon. J Virol (1996) 0.96
Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts. J Immunol (1977) 0.95
Expression of GD3 ganglioside in childhood T-cell lymphoblastic malignancies. Cancer Res (1987) 0.93
Immunological evaluation of pediatric cancer patients receiving recombinant interleukin-2 in a phase I trial. J Immunother (1991) (1992) 0.93
Shifts in expression of cell membrane phenotypes in childhood lymphoid malignancies at relapse. Blood (1979) 0.91
Treatment of therapy-refractory B-lineage acute lymphoblastic leukemia with an apoptosis-inducing CD19-directed tyrosine kinase inhibitor. Clin Cancer Res (1999) 0.90
Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo. J Immunol (1983) 0.90
Reactivity of human brain antiserum with neuroblastoma cells and nonreactivity with thymocytes and lymphoblasts. Cancer Res (1977) 0.90
HLA gene amplification and hybridization analysis of polymorphism. HLA matching for bone marrow transplantation of a patient with HLA-deficient severe combined immunodeficiency syndrome. J Clin Invest (1989) 0.89
Therapeutic plasma exchange does not appear to be effective in the management of thrombotic thrombocytopenic purpura/hemolytic uremic syndrome following bone marrow transplantation. Bone Marrow Transplant (1995) 0.88
The replication of bovine viral diarrhea-mucosal disease virus in bovine leukocytes in vitro. Arch Gesamte Virusforsch (1973) 0.88
Delayed infusion of normal donor cells after MHC-matched bone marrow transplantation provides an antileukemia reaction without graft-versus-host disease. Bone Marrow Transplant (1993) 0.87
Role of immunoregulatory donor T cells in suppression of graft-versus-host disease following donor leukocyte infusion therapy. J Immunol (1999) 0.87
Cytosine arabinoside/cyclophosphamide pulses during continuation therapy for childhood acute lymphoblastic leukemia. Potential selective effect in T-cell leukemia. Cancer (1987) 0.86
Low-dose chemotherapy as a prelude to intensive treatment of spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst (1975) 0.86
Graft-vs.-host and graft-vs.-leukemia reactions after delayed infusions of donor T-subsets. Biol Blood Marrow Transplant (1999) 0.86
Distinguishing characteristics of a new neuroblastoma cell line. Cancer Genet Cytogenet (1983) 0.86
Sca1(+)/Mac1(+) nitric oxide-producing cells in the spleens of recipients early following bone marrow transplant suppress T cell responses in vitro. Cell Immunol (1998) 0.84
In vitro enhancement of peripheral blood mononuclear cell natural killer activity following short term incubation with fetal calf serum. J Clin Lab Immunol (1983) 0.83
Allogeneic bone marrow chimerism in germfree mice. 1. Prevention of spontaneous leukemia in AKR mice. Proc Soc Exp Biol Med (1973) 0.82
A decrease in graft-vs.-host disease without loss of graft-vs.-leukemia reactivity after MHC-matched bone marrow transplantation by selective depletion of donor NK cells in vivo. Transplantation (1992) 0.81
Interstitial nephritis due to phenytoin hypersensitivity. J Pediatr (1977) 0.81
Use of anti-CD3 epsilon F(ab')2 fragments in vivo to modulate graft-versus-host disease without loss of graft-versus-leukemia reactivity after MHC-matched bone marrow transplantation. J Immunol (1995) 0.81
Allogeneic bone marrow chimerism in germ-free mice. IV. Therapy of "Hodgkin's-like" reticulum cell sarcoma in SJL mice. Transplantation (1976) 0.81
Isolated bilateral T-cell renal lymphoblastic lymphoma. Am J Pediatr Hematol Oncol (1986) 0.80
Association between HLA-D region antigens and disease-free survival in childhood non-T, non-B acute lymphocytic leukemia. Blood (1982) 0.80
Bone marrow and extramedullary variations of cell membrane antigen expression in childhood lymphoid neoplasias at relapse. Leuk Res (1982) 0.80
Ultrastructural examination of phytohemagglutinin stimulated lymphocytes infected with vesicular stomatitis virus. Arch Gesamte Virusforsch (1973) 0.80
Effectiveness of a six-drug regimen (APO) without local irradiation for treatment of mediastinal lymphoblastic lymphoma in children. Cancer (1985) 0.80
Cell differentiation antigens versus tumor-related antigens in childhood acute lymphoblastic leukemia (ALL). Clinical significance of leukemia markers. Haematol Blood Transfus (1977) 0.79
Preservation of lymphokine-activated killer activity following T cell depletion of human bone marrow. Transplantation (1990) 0.79
Evaluation of histogenesis of B-lymphocytes in pediatric EBV-related post-transplant lymphoproliferative disorders. Bone Marrow Transplant (2004) 0.79
Clinical pharmacokinetics of the CD19 receptor-directed tyrosine kinase inhibitor B43-Genistein in patients with B-lineage lymphoid malignancies. J Clin Pharmacol (1999) 0.78
Late renal dysfunction in adult survivors of bone marrow transplantation. Cancer (1991) 0.78
Kinetic analysis of human IL-2 activated cytotoxic cells. Immunopharmacol Immunotoxicol (1991) 0.78
Kinetic analysis of cloned cytotoxic T lymphocyte reactivity against normal and leukaemic target cells. J Immunogenet (1987) 0.78
Technical modifications in hyperfractionated total body irradiation for T-lymphocyte deplete bone marrow transplant. Int J Radiat Oncol Biol Phys (1989) 0.78
Extraosseous accumulation of Tc-99m MDP. Metastatic intracranial neuroblastoma. Clin Nucl Med (1983) 0.78
Graft versus leukemia. VI. Adoptive immunotherapy in combination with chemoradiotherapy for spontaneous leukemia-lymphoma in AKR mice. J Natl Cancer Inst (1975) 0.77
Manipulation of graft-versus-host disease for a graft-versus-leukemia effect after allogeneic bone marrow transplantation in AKR mice with spontaneous leukemia/lymphoma. Transplantation (1986) 0.77
Alloimmunization and adoptive immunotherapy of leukemia. Transplant Proc (1981) 0.77
Reye syndrome. A correlated electron-microscopic, viral, and biochemical observation. JAMA (1975) 0.77
Donor natural killer (NK1.1+) cells do not play a role in the suppression of GVHD or in the mediation of GVL reactions after DLI. Biol Blood Marrow Transplant (2001) 0.77
Kinetic analysis of Qa-1-specific cloned cytotoxic T lymphocytes: lytic parameters and evaluation of cellular inhibition. Scand J Immunol (1987) 0.77
The graft-versus-leukemia effect of post-transplant donor leukocyte infusion. Leuk Lymphoma (1996) 0.77
T-cell depletion in allogeneic bone marrow transplantation: progress and problems. Haematologica (1990) 0.77
Infiltrating T cells during liver graft-versus-host disease show a restricted T-cell repertoire. Biol Blood Marrow Transplant (2000) 0.77
HTLV-III serology in hemophilia: relationship with immunologic abnormalities. J Pediatr (1986) 0.76
Cyclic neutropenia in identical twins. Am J Med (1986) 0.76
Allogeneic bone marrow chimerism in germ-free mice. II. Prevention of reticulum cell sarcomas in SJL-J mice. Proc Soc Exp Biol Med (1974) 0.76
Detection of Epstein-Barr virus EBER sequence in post-transplant lymphoma patients with DNA dendrimers. J Virol Methods (1999) 0.76
Hematologic and immunologic evaluation of recombinant human interleukin-6 in patients with advanced malignant disease: evidence for monocyte activation. J Immunother Emphasis Tumor Immunol (1996) 0.75
Immunodiagnosis of childhood ALL: problems associated with the use of peripheral blood alone. Med Pediatr Oncol (1979) 0.75
Alternative donor bone marrow transplant for children with Philadelphia chromosome ALL. Bone Marrow Transplant (2006) 0.75
Partially matched bone marrow transplantation in patients with myelodysplastic syndromes. J Clin Oncol (1988) 0.75
Neutropenia in dysgammaglobulinemia I: remission with immunoglobulin therapy. Wis Med J (1981) 0.75
Fractionated total body irradiation for metastatic neuroblastoma. Int J Radiat Oncol Biol Phys (1981) 0.75
Bone scintigraphy: retroperitoneal fibrosis. Wis Med J (1980) 0.75
Clinical cancer: 33. Clinical applications and research advances in marrow transplantation. Wis Med J (1988) 0.75
Transient appearance of HLA-DRw-positive leukocytes in peripheral blood after cessation of antileukemia therapy. Transplant Proc (1980) 0.75
The autologous mixed lymphocyte response: isolation of mononuclear cell populations by counterflow centrifugal elutriation. J Clin Lab Immunol (1988) 0.75
Cloning of human neuroblastoma cells in soft agar. Prog Clin Biol Res (1980) 0.75
Bone scintigraphy in neuroblastoma with ovarian metastasis. Wis Med J (1980) 0.75